JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (1): 67-72.doi: 10.6040/j.issn.1671-7554.0.2014.078
Previous Articles Next Articles
MA Honghai, DU Jiajun
CLC Number:
[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917. [2] 郭梅,赵一电,杨海军,等.食管肿瘤5406例临床病理特点对比分析[J].中华肿瘤防治杂志,2008,15(1):54-56. GUO Mei, ZHAO Yidian, YANG Haijun, et al. Analysis of clinicopathological characteristics for 5406 cases of esophageal neoplasm[J]. Chin J Cancer Prev Treat, 2008, 15(1): 54-56. [3] Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development[J]. Asian Pac J Cancer Prev, 2011, 12(10): 2461-2466. [4] Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals[J]. Cancer, 2010, 116(16):3763-3773. [5] Casson AG, Rusch VW, Ginsberg RJ, et al. Lymph node mapping of esophageal cancer[J]. Ann Thorac Surg, 1994, 58(5): 1569-1570. [6] Mawhinney MR, Glasgow RE. Current treatment options for the management of esophageal cancer[J]. Cancer Manag Res, 2012, 4: 367-377. [7] Situ D, Wei W, Lin P, et al. Do tumor grade and location affect survival in esophageal squamous cell carcinoma? survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma[J]. Ann Surg Oncol, 2013, 20(2): 580-585. [8] Yu Y, Wang Z, Liu XY, et al. Therapeutic efficacy comparison of two surgical procedures to treat middle thoracic esophageal carcinoma[J]. World J Surg, 2009, 34(2): 272-276. [9] Fox M1, Farmer R, Scoggins CR, et al. Lymph node ratio is a significant predictor of disease specific mortality in patients undergoing esophagectomy for cancer[J]. Am Surg, 2012, 78(5): 528-534. [10] Hsu WH, Hsu PK, Hsieh CC, et al. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer[J]. J Gastrointest Surg, 2009, 13(11): 1913-1920. [11] Lee L, Sudarshan M, Li C, et al. Cost-effectiveness of minimally invasive versus open esophagectomy for esophageal cancer[J]. Ann Surg Oncol, 2013, 20(12): 3732-3739. [12] 李杰, 田锋, 林长锦, 等. 不同手术方式对胸中段食管癌的近期和远期疗效评估[J]. 实用临床医药杂志, 2013, 17(21): 50-52. LI Jie, TIAN Feng, LIN Changjin, et al. Effects of short-term and long-term evaluation of different operation methods on the middle thoracic esophageal carcinoma[J]. Journal of Clinical Medicine in Practice,2013, 17(21): 50-52. [13] 尤振兵, 徐达夫, 朱卫国, 等. 两种手术入路治疗420例胸中段食管癌的疗效比较[J]. 实用医学杂志, 2011, 27(13): 2353-2355. YOU Zhenbing, XU Dafu, ZHU Weiguo, et al. To compare the therapeutic effect of two kinds of transthoracic operative approach for 420 patients with middle thoracic esophageal cancer[J]. The Journal of Practical Medicine, 2011, 27(13): 2353-2355. [14] 罗强, 蓝碧洋, 钟醒能, 等. 两种径路治疗胸中段食管癌的手术评价[J]. 河北医学, 2012, 18(6): 746-748. [15] Song L, Liu Y, Wang Z, et al. Curative effect comparision between ivor-lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma[J]. Hepatogastroenterology, 59(115): 738-741. |
[1] |
ZHANG Zhen-wei1, JIANG Zhong-min2.
Expression and clinical significance of Mel-18 mRNA in esophageal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 78-. |
[2] | SUN Xiaohong, PANG Zuoliang, LUO Dongbo. Expressions of MMP-7 and MMP-2 in esophageal cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 102-104. |
|